Clinical trial
Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)
NCT00337051 · University Hospital, Bordeaux, Other · Completed
Key facts
| NCT number | NCT00337051 |
|---|---|
| Title | Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN) |
| Official title | Sevoflurane-induced Prevention of Ischemia-reperfusion Lesions in Renal Allograft Transplants Recipients |
| Acronym | SévoRein |
| Lead sponsor | University Hospital, Bordeaux, Other |
| Collaborators | Ministry of Health, France |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | End-stage Chronic Renal Disease, Severe Acute Kidney Failure, Renal Transplantation |
| Intervention type | Drug |
| Interventions | Sevoflurane, Propofol |
| Enrollment | 120 |
| Start date | Jun 1, 2006 |
| Primary completion | Feb 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Jun 15, 2006 |
| Last update posted | Jun 23, 2010 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: